Skip to Content
Merck
  • C17orf53 is identified as a novel gene involved in inter-strand crosslink repair.

C17orf53 is identified as a novel gene involved in inter-strand crosslink repair.

DNA repair (2020-08-28)
Chao Wang, Zhen Chen, Dan Su, Mengfan Tang, Litong Nie, Huimin Zhang, Xu Feng, Rui Wang, Xi Shen, Mrinal Srivastava, Megan E McLaughlin, Traver Hart, Lei Li, Junjie Chen
ABSTRACT

Ataxia Telangiectasia and Rad3-Related kinase (ATR) is a master regulator of genome maintenance, and participates in DNA replication and various DNA repair pathways. In a genome-wide screen for ATR-dependent fitness genes, we identified a previously uncharacterized gene, C17orf53, whose loss led to hypersensitivity to ATR inhibition. C17orf53 is conserved in vertebrates and is required for efficient cell proliferation. Loss of C17orf53 slowed down DNA replication and led to pronounced interstrand crosslink (ICL) repair defect. We showed that C17orf53 is a ssDNA- and RPA-binding protein and both characteristics are important for its functions in the cell. In addition, using multiple omics methods, we found that C17orf53 works with MCM8/9 to promote cell survival in response to ICL lesions. Taken together, our data suggest that C17orf53 is a novel component involved in ICL repair pathway.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MISSION® esiRNA, targeting human C17ORF53
Sigma-Aldrich
Samarium(III) acetate hydrate, 99.9% trace metals basis
Sigma-Aldrich
Anti-C17orf53 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab2